awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36661836-2DBD3E40-5520-42CD-89AB-CC2176270E84
Q36661836-2DBD3E40-5520-42CD-89AB-CC2176270E84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36661836-2DBD3E40-5520-42CD-89AB-CC2176270E84
An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agents.
P2860
Q36661836-2DBD3E40-5520-42CD-89AB-CC2176270E84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36661836-2DBD3E40-5520-42CD-89AB-CC2176270E84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c351088d12f152a9e85f8c821fdde7a851d010a5
P2860
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.